A commenter argued that Kisspeptin-10 is largely ineffective for raising LH and FSH levels due to its extremely short half-life. They suggested that its clinical utility is limited compared to sustained-release versions or other treatments.
A commenter argued that Kisspeptin-10 is largely ineffective for raising LH and FSH levels due to its extremely short half-life. They suggested that its clinical utility is limited compared to sustained-release versions or other treatments.